• OPEN AN ACCOUNT
Indian Indices
Sensex
73,123.83 -125.56
( -0.17%)
Global Indices
Nasdaq
52,230.09 -658.89
(-1.25%)
Dow Jones
7,644.13 -40.30
(-0.52%)
Hang Seng
62,584.98 -322.86
(-0.51%)
Nikkei 225
10,670.63 -54.40
(-0.51%)
Forex
USD-INR
94.61 0.10
(0.11%)
EUR-INR
106.18 0.08
(0.07%)
GBP-INR
126.70 0.19
(0.15%)
JPY-INR
0.60 0.00
(0.70%)

EQUITY - MARKET SCREENER

KD Green Industries Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
512595
INE348N01042
6.3106821
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
KDGREEN
0
487.25
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

Indegene's US arm settles TCPA class-action litigation for $4.72 million
Aug 19,2026

The case relates to alleged unsolicited fax communications sent in February 2020. The certified class covers approximately 18,851 unique fax numbers and 18,869 transmissions.

The Telephone Consumer Protection Act (TCPA) prohibits automated calls or texts to consumers without prior consent, including calls using prerecorded or synthetic voices, and protects numbers listed on the National Do-Not-Call Registry in the US.

When companies violate these rules, affected individuals can reportedly pursue statutory damages ranging from $500 to $1,500 per call or text received.

The proposed settlement provides for a maximum settlement fund of US$4.72 million, calculated at US$250 per eligible claim.

However, the $4.72 million represents the contractual maximum and is not the expected cash outflow.

The actual payment will depend on the number of valid claims submitted and approved under the settlement framework.

The settlement is also subject to execution by the relevant parties and approval by the US District Court for the District of New Jersey.

'The settlement does not constitute an admission of liability by the company or the defendants,' Indegene said in a statement.

Indegene is the strategic operating partner to the global life sciences industry, orchestrating commercial, medical, R&D, and safety operations across the product lifecycle.

The company's net profit remained almost flat at Rs 116.2 crore even as revenues rose by 39.7% to Rs 1,063.1 crore in Q1 FY27 as compared with Q1 FY26.

The scrip shed 0.66% to currently trade at Rs 563.30 on the BSE.